Pharma Journalist -

SMi is delighted to announce its 2nd Annual Highly Potent Active Pharmaceutical Ingredients conference coming to London on the 21st - 22nd May 2018. There is a £100 saving when booking…
Read More...

Forendo Pharma which is a drug development company developing novel oral treatments for endometriosis patients asserted the appointment of David Colpman as a Non-executive Director to…
Read More...

Building on the success of SMi's 10th Annual Flagship Conference Pre-Filled Syringes, SMi are thrilled to present the launch of their Injectable Drug Delivery conference being held at…
Read More...

23andMe which is the leading personal genetics company received FDA Authorization for a direct-to-consumer genetic test for cancer risk.The authorization allows 23andMe to provide…
Read More...

Theratechnologies and its partner TaiMed Biologics, Inc. (TaiMed) asserted that the U.S. Food and Drug Administration (FDA) has granted approval of Trogarzo (ibalizumab-uiyk) Injection.…
Read More...

The U.S Food and Drug Administration has sanctioned Trogarzo which is a new type of antiretroviral medication for adult patients living with HIV who have tried multiple HIV medications…
Read More...

The U.S Food and Drug Administration has sanctioned the Imugen Babesia microti Arrayed Fluorescent Immunoassay (AFIA), for the detection of antibodies to Babesia microti (B. microti) in…
Read More...

Contego Medical has affirmed the enrollment in the PERFORMANCE I Trial, a clinical trial designed to evaluate the safety and feasibility of the Neuroguard IEP 3-in-1 Carotid Stent and…
Read More...

Magenta Therapeutics which is a biotechnology company developing therapeutics to enhance and extend the use of curative bone marrow transplant for more patients and Heidelberg Pharma AG…
Read More...

City of Hope scientists and doctors have discerned a more effective treatment for patients with Chronic myelogenous leukemia using a drug that was developed at the Institution to…
Read More...